Universal Health Services (UHS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
28 Apr, 2026Executive summary
Achieved 9.6% revenue growth and 16.1% adjusted EPS growth year-over-year for Q1 2026, with net income attributable to shareholders rising to $348.7 million ($5.65 per diluted share).
EBITDA net of NCI reached $651.7 million, up from $603.9 million year-over-year, and adjusted net income was $346.5 million ($5.62 per diluted share).
Announced and closed acquisition of Talkspace, a leading virtual behavioral health platform, expected to accelerate outpatient strategy and be accretive to earnings within 12 months post-closing.
Maintained steady operating performance and cash flow despite challenging seasonal volume trends.
Continued investment in technology and operational efficiency, including AI deployment in revenue cycle and clinical operations.
Financial highlights
Net income per diluted share was $5.65; adjusted EPS was $5.62 for Q1 2026.
Net revenues increased 9.6% year-over-year to $4.495 billion in Q1 2026.
Cash from operating activities was $402 million, up from $360 million year-over-year.
Capital expenditures totaled $217 million in Q1 2026.
Repurchased 675,000 shares for $127 million; $1.3 billion buyback authorization remains.
Outlook and guidance
Reiterated full-year 2026 financial and operating guidance set in February.
Expects earnings ramp through the year to achieve core 5% growth target, with volume and pricing more balanced as seasonal impacts subside.
Guidance includes $75 million pre-tax impact from health insurance exchange (HIX) declines, expected to steepen as the year progresses.
Management highlighted risks from changes in Medicaid and Medicare funding, new legislation affecting Medicaid eligibility, and interest rate volatility.
The company expects potential impacts from the integration of the proposed Talkspace acquisition.
Latest events from Universal Health Services
- Virtual annual meeting to vote on director, pay, auditor, and ESG-related proposals.UHS
Proxy filing9 Apr 2026 - Board recommends for director elections and compensation, against both shareholder proposals.UHS
Proxy filing9 Apr 2026 - Strong 2025 growth and higher 2026 outlook, but regulatory and funding risks persist.UHS
Q4 20258 Apr 2026 - Talkspace acquisition and AI investments drive outpatient growth and operational efficiency.UHS
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Acquisition of Talkspace boosts outpatient behavioral health and virtual care capabilities.UHS
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance targets 2%-3% volume growth, with focus on staffing, outpatient, and AI initiatives.UHS
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Director elections and auditor ratification passed; annual director election proposal failed.UHS
AGM 20253 Feb 2026 - Q2 net income surged 69% and 2024 guidance was raised; $1B added to share repurchase.UHS
Q2 20242 Feb 2026 - Strong acute volumes, robust behavioral pricing, and margin recovery drive positive outlook.UHS
Goldman Sachs 45th Annual Global Healthcare Conference22 Jan 2026